NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Cash Flow
NASDAQ:NRSN - Nasdaq - IL0011809592 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.21M | -11.28M | -12.34M | -4.04M | -2.83M | |||
| Depreciation Amortization | 22.00K | 21.00K | 90.00K | 0.00 | 0.00 | |||
| Change In Working Capital | -781.00K | 1.91M | 730.00K | 270.00K | 70.00K | |||
| Other non cash items | 834.00K | -181.00K | 3.94M | 2.23M | 2.06M | |||
| OPERATING CASH FLOW | -10.13M | -8.35M | -7.59M | -1.54M | -700.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.00K | -29.00K | -70.00K | -20.00K | -10.00K | |||
| Other Investing Activity | 4.00K | 3.50M | -3.47M | 0.00 | N/A | |||
| INVESTING CASH FLOW | 1.00K | 3.47M | -3.54M | -20.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -80.00K | -80.00K | N/A | N/A | |||
| Stock Issued/Repurchased | 11.30M | 4.34M | 3.87M | 11.10M | 510.00K | |||
| Other Financing Activity | -391.00K | -364.00K | -100.00K | 800.00K | N/A | |||
| FINANCING CASH FLOW | 10.91M | 3.98M | 3.70M | 11.90M | 510.00K | |||
| Exchange Rate Effect | -41.00K | 8.00K | -90.00K | 20.00K | N/A | |||
| CHANGE IN CASH | 738.00K | -903.00K | -7.52M | 10.36M | -200.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.13M | -8.35M | -7.59M | -1.54M | -700.00K | |||
| Capital Expenditure | -3.00K | -29.00K | -70.00K | -20.00K | -10.00K | |||
| FREE CASH FLOW | -10.14M | -8.38M | -7.66M | -1.56M | -710.00K | |||
All data in USD